HIGHLIGHTS
- who: Argelia Calvillo-Robledo from the University of Salamanca, Spain have published the article: Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment, in the Journal: (JOURNAL)
- what: These differences and similarities show the potential use of in_vivo models in preclinical_trials, with the main objective of finding the best model that can replicate the pathophysiological conditions of the disease, consequently their study is key to understanding the disease, as well as the creation of possible therapeutic targets for patients with MS (Mix et_al, 2010; Constantinescu . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.